Clinical trial
Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in…
NCT00160329 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00160329 |
|---|---|
| Title | Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia |
| Official title | The De-Escalate Trial: Atazanavir or Atazanavir/Ritonavir Substitution for Ritonavir Boosted PI Therapy in HIV-Infected Individuals Experiencing Ongoing HIV Viremia and Hyperlipidemia: A Randomized Controlled Pilot Study |
| Lead sponsor | Stanford University, Other |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hyperlipidemia, HIV Infections |
| Intervention type | Drug |
| Interventions | Atazanavir |
| Enrollment | 60 |
| Start date | Jan 1, 2004 |
| Primary completion | Apr 1, 2007 |
| Completion | Mar 1, 2009 |
| First posted | Sep 12, 2005 |
| Last update posted | Jul 21, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: